中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2018, Vol. 47 ›› Issue (1): 22-26.doi: 10.12007/j.issn.0258-4646.2018.01.006

• 论著 • 上一篇    下一篇

GATA1不同激酶活性突变体质粒的构建及蛋白表达和亚细胞定位

李丹妮, 刘云鹏   

  1. 中国医科大学附属第一医院肿瘤内科, 沈阳 110001
  • 收稿日期:2017-05-16 出版日期:2018-01-30 发布日期:2017-12-23
  • 通讯作者: 刘云鹏 E-mail:lypcmu@163.com
  • 作者简介:李丹妮(1989-),女,助教,硕士.
  • 基金资助:
    国家自然科学基金(81372546)

Construction,Protein Expression,and Subcellular Localization of Various Kinase Mutant Plasmids of GATA1

LI Danni, LIU Yunpeng   

  1. Department of Oncology, The First Hospital, China Medical University, Shenyang 110001, China
  • Received:2017-05-16 Online:2018-01-30 Published:2017-12-23

摘要: 目的 采用大引物法构建GATA1不同激酶活性突变体GATA1 S161A S187A(死型)和GATA1 S161D S187D(激活型)真核表达载体,并证实其融合蛋白在细胞内的表达及定位,旨在进一步探讨其生物学功能和潜在肿瘤治疗靶点。方法 以GFP-GATA1 WT为模板,采用大引物法扩增S161A S187A、S161D S187D突变体片段,双酶切克隆至pEGFP-C1表达载体中,将重组质粒转染至HEK293中,经免疫印迹鉴定融合蛋白的表达。结果 用大引物PCR法成功构建GATA1不同激酶活性突变体的真核表达载体pEGFP-GATA1 S161A S187A和pEGFP-GATA1 S161D S187D,验证了其融合蛋白表达。共聚焦激光显微镜技术显示,融合蛋白主要定位于细胞核内。结论 利用大引物法成功构建GATA1不同激酶活性突变体真核表达载体,并为进一步进行该突变体的结构和功能研究奠定了基础。

关键词: GATA1, PAK5, 磷酸化, 基因克隆, 融合蛋白, 转染

Abstract: Objective The GATA1 mutant GATA1 S161A S187A (death type) and GATA1 S161D S187D (activated) eukaryotic expression vectors were constructed using the large primer method,and,to explore their biological function and potential tumor treatment targets,the expression and localization of the fusion protein in cells were confirmed. Methods S161A,S187A,S161D,and S187D mutants were amplified by GFP-GATA1 WT,which served as the template. The recombinant plasmid was cloned into a pEGFP-C1 expression vector and transfected into HEK293 cells by immunoblotting expression of the fusion protein. Results The eukaryotic expression vectors pEGFP-GATA1 S161A S187A and pEGFP-GATA1 S161D S187D were successfully constructed using the high primer PCR method,and expression of the fusion protein was verified. Confocal laser microscopy showed that the fusion protein was mainly located in the nuclei of HEK293 cells. Conclusion A eukaryotic expression vector of a GATA1 mutant was successfully constructed using the large primer method. This work lays the foundation for further studies on the structure and function of the mutant.

Key words: GATA1, PAK5, phosphorylation, gene cloning, fusion protein, transfect

中图分类号: 

  • R730.23
[1] SCHRANTZN,DA SILVA CORREIA J,FOWLER B,et al. Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling[J]. J Biol Chem,2004,279(3),1922-1931.DOI:10.1074/jbc.M311145200.
[2] KEXIN X,HERMELA S. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination[J]. Cancer Cell,2009,15(4):270-282.DOI:10.1016/j.ccr.2009.02.021.
[3] KATSUMURA KR,BRESNICK EH,GATA FACTOR MECHANISM GROUP. The GATA factor revolution in hematology[J]. Blood,2017,129(15):2092-2102. DOI:10.1182/blood-2016-09-687871.
[4] WELLS CM,JONES GE. The emerging importantce of group Ⅱ PAKs[J]. Biochem J,2010,425(3):465-473. DOI:10.1042/BJ20091173.
[5] POONAM RM,LI DQ,MURRAY B,et al. PAK signaling in oncogenesis[J]. Oncogene,2009,28(28):2545-2555. DOI:10.1038/onc.
[6] DUMMLER B,OHSHIRO K,KUAMR R,et al. Pak protein kinases and their role in cancer[J]. Cancer Metast Rev,2009,28(1/2):51-63. DOI:10.1007/s10555-008-9168-1.
[7] YE DZ,FIELD J. PAK signaling in cancer[J]. Cell Logist,2012,2(2):105-116. DOI:10.4161/cl.21882
[8] ISSACS JT,ISAACS WB. Androgen receptor outwits prostate cancer drugs[J]. Nat Med,2004,10(1):26-27. DOI:10.1038/nm0104-26.
[9] YANG F,LI X,SHARMA M,et al. Androgen receptor specifically interacts with a novel p21-activated kinase PAK6[J]. J Biol Chem,2001,276(18):15345-15353. DOI:10.1074/jbc.M010311200.
[10] LEE SR,RAMOS SM,KO A. AR and ER interaction with a p21-activated kinase (PAK6)[J]. Mol Endocrinol,2002,16(6):85-99. DOI:10.1210/mend.16.1.0753.
[11] YANG LI,QIANG KE. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling[J]. Oncotarget,2015,6(6):4345-4356. DOI:10.18632/oncotarget.2999.
[12] KAMMANN M,LAUFS J,GRONENBORN B. Rapid insertional mutagenesis of DNA by polymerase chain reaction (PCR)[J].Nucleic Acids Res,1989,17(13):5404.
[13] SARKAR G,SOMMER SS. The "megaprimer" method of site-directed mutagenesis[J]. Biol Techniques,1990,8(4):404-407.
[1] 解丽丽, 吕洪涛, 许瑞雪. 磷酸化P38在神经病理性疼痛大鼠背根神经节中的作用机制[J]. 中国医科大学学报, 2018, 47(4): 308-311.
[2] 郭冰玉, 回蔷, 常鹏, 陶凯. miR-489通过打靶PAK5抑制黑色素瘤的迁移[J]. 中国医科大学学报, 2018, 47(4): 355-357,363.
[3] 田玉楼, 于默, 史娅婕, 张薇. OTX2基因表达下调对MC3T3-E1细胞增殖分化和自噬的影响[J]. 中国医科大学学报, 2018, 47(11): 1015-1020.
[4] 郭琳琳,李哲,柯娴,陈志伟,吴南锦,张越. miR-21 对 HeLa 细胞增殖、凋亡和 MMP2 基因表达的影响[J]. 中国医科大学学报, 2016, 45(7): 583-586.
[5] 赵美眯,李卓,邵冬雪,梁洪玥,晏珊,封瑞,孙雪菲,郭凤,郝丽英. 钙调蛋白镁结合位点突变体载体的构建、表达纯化及鉴定[J]. 中国医科大学学报, 2016, 45(5): 394-397.
[6] 关阳阳,肖明扬,潘亮,薛萍,张国培,逯晓波. 应用转染细胞研究 ERCC2/XPD 基因多态与短波紫外线 所致 DNA 损伤修复的关联[J]. 中国医科大学学报, 2016, 45(12): 1066-1071.
[7] 王欢,乔俏,解海涛,勾宏图,李光. 鼻咽癌 p-IRE1 蛋白表达与放射治疗预后的关系[J]. 中国医科大学学报, 2016, 45(10): 926-931.
[8] 雷明, 赵美眯, 封瑞, 王红梅, 毛楠, 朱彤, 郝丽英. Cav1.2通道CT1片断突变体的质粒构建和蛋白表达[J]. 中国医科大学学报, 2015, 44(9): 837-839.
[9] 徐璐,石晶,张凌云,时莎,曲晶磊,李智,侯科佐,曲秀娟,滕月娥. FAK及pAKT在乳腺癌中的表达及预后分析[J]. 中国医科大学学报, 2015, 44(8): 673-678.
[10] 封瑞,刘彦,杨磊,胡慧媛,郭凤,赵美眯,赵金生,郝丽英. 豚鼠钙调蛋白2基因编码区及3′端非编码区序列克隆[J]. 中国医科大学学报, 2015, 44(2): 123-126.
[11] 张亘,黄燕红,李静. 磷酸化P53与ERα在乳头状甲状腺癌中的相关性研究[J]. 中国医科大学学报, 2015, 44(1): 51-54.
[12] 张男,赵茗,孙亚澎. 川芎嗪对大鼠脊髓损伤后运动功能恢复的影响及机制[J]. 中国医科大学学报, 2015, 44(1): 60-63.
[13] 张秀伟,,郝凤霞,贺佳妮,谢玲玲,付琳,董千泽,李庆昌. 染色质重塑因子1在肺癌中过表达并促进肺癌增殖能力[J]. 中国医科大学学报, 2014, 43(9): 821-825.
[14] 崔慧霞,张文陆. 腺病毒转染与蛋白负载在促进树突状细胞成熟中的作用对比[J]. 中国医科大学学报, 2014, 43(8): 742-744.
[15] 梁德勇,陈升,王野,富伟能. miR?24?2对人骨肉瘤细胞系U?2OS体外增殖能力的影响[J]. 中国医科大学学报, 2014, 43(5): 393-395.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA